BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 34729791)

  • 1. Glycogen synthesis and beyond, a comprehensive review of GSK3 as a key regulator of metabolic pathways and a therapeutic target for treating metabolic diseases.
    Wang L; Li J; Di LJ
    Med Res Rev; 2022 Mar; 42(2):946-982. PubMed ID: 34729791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose dependence of glycogen synthase activity regulation by GSK3 and MEK/ERK inhibitors and angiotensin-(1-7) action on these pathways in cultured human myotubes.
    Montori-Grau M; Tarrats N; Osorio-Conles O; Orozco A; Serrano-Marco L; Vázquez-Carrera M; Gómez-Foix AM
    Cell Signal; 2013 May; 25(5):1318-27. PubMed ID: 23453973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen synthase kinase-3 inhibition induces glioma cell death through c-MYC, nuclear factor-kappaB, and glucose regulation.
    Kotliarova S; Pastorino S; Kovell LC; Kotliarov Y; Song H; Zhang W; Bailey R; Maric D; Zenklusen JC; Lee J; Fine HA
    Cancer Res; 2008 Aug; 68(16):6643-51. PubMed ID: 18701488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in the Therapeutic Potential of Inhibitors Targeting Glycogen Synthase Kinase 3 in Inflammatory Diseases.
    Zhu Y; Wang H; Guo Y; Cao J; Li H
    Mini Rev Med Chem; 2023; 23(19):1893-1904. PubMed ID: 37055897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase.
    MacAulay K; Hajduch E; Blair AS; Coghlan MP; Smith SA; Hundal HS
    Eur J Biochem; 2003 Sep; 270(18):3829-38. PubMed ID: 12950267
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute selective glycogen synthase kinase-3 inhibition enhances insulin signaling in prediabetic insulin-resistant rat skeletal muscle.
    Dokken BB; Sloniger JA; Henriksen EJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1188-94. PubMed ID: 15671078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role that phosphorylation of GSK3 plays in insulin and Wnt signalling defined by knockin analysis.
    McManus EJ; Sakamoto K; Armit LJ; Ronaldson L; Shpiro N; Marquez R; Alessi DR
    EMBO J; 2005 Apr; 24(8):1571-83. PubMed ID: 15791206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of GSK3 in glucose homeostasis and the development of insulin resistance.
    Lee J; Kim MS
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S49-57. PubMed ID: 17478001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insulin promotes glycogen synthesis in the absence of GSK3 phosphorylation in skeletal muscle.
    Bouskila M; Hirshman MF; Jensen J; Goodyear LJ; Sakamoto K
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E28-35. PubMed ID: 18003720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen synthase kinase 3: more than a namesake.
    Rayasam GV; Tulasi VK; Sodhi R; Davis JA; Ray A
    Br J Pharmacol; 2009 Mar; 156(6):885-98. PubMed ID: 19366350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycogen synthase kinase 3 (GSK3) in the heart: a point of integration in hypertrophic signalling and a therapeutic target? A critical analysis.
    Sugden PH; Fuller SJ; Weiss SC; Clerk A
    Br J Pharmacol; 2008 Mar; 153 Suppl 1(Suppl 1):S137-53. PubMed ID: 18204489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases.
    Beurel E; Grieco SF; Jope RS
    Pharmacol Ther; 2015 Apr; 148():114-31. PubMed ID: 25435019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage Function and the Role of GSK3.
    Patel S; Werstuck GH
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672232
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of the porcine glycogen synthase kinase 3β (GSK-3β) gene with differential expression patterns and regulatory functions.
    Wang L; Zuo B; Xu D; Ren Z; Zhang H; Li X; Lei M; Xiong Y
    PLoS One; 2012; 7(7):e40250. PubMed ID: 22792253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Constitutive activation of GSK3 down-regulates glycogen synthase abundance and glycogen deposition in rat skeletal muscle cells.
    MacAulay K; Blair AS; Hajduch E; Terashima T; Baba O; Sutherland C; Hundal HS
    J Biol Chem; 2005 Mar; 280(10):9509-18. PubMed ID: 15632169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of GSK3 inhibitors for the treatment of type 2 diabetes.
    Wagman AS; Johnson KW; Bussiere DE
    Curr Pharm Des; 2004; 10(10):1105-37. PubMed ID: 15078145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors.
    Wadhwa P; Jain P; Jadhav HR
    Curr Top Med Chem; 2020; 20(17):1522-1534. PubMed ID: 32416693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GSK3β isoform-selective regulation of depression, memory and hippocampal cell proliferation.
    Pardo M; Abrial E; Jope RS; Beurel E
    Genes Brain Behav; 2016 Mar; 15(3):348-55. PubMed ID: 26749572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of prior exercise on components of insulin signalling in equine skeletal muscle.
    McCutcheon LJ; Geor RJ; Pratt SE; Martineau E; Ho K
    Equine Vet J Suppl; 2006 Aug; (36):330-4. PubMed ID: 17402442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.